Analysis of the dynamics of expenditures on pharmaceutical support of population in Ukraine, Belarus republic and in European Union
Journal Title: ScienceRise: Pharmaceutical Science - Year 2019, Vol 0, Issue 4
Abstract
<p><strong>Aim</strong>: comparative analysis the dynamics of changes in the indices of expenditures (%) on pharmaceutical provision of population from total health expenditure at the macroeconomic level in Ukraine, the Republic of Belarus (RB) and the countries of the European Union (EU).</p><p><strong>Materials and methods.</strong> The studies used data from the World Health Organization and its Regional Office for Europe, as well as data from the legislative and regulatory framework regulating medical and pharmaceutical activities in Ukraine, the Republic of Belarus and the EU. Historical, analytical-comparative, systemic, logical, graphic, mathematical-statistical methods of scientific search and knowledge were used.</p><p><strong>Results.</strong> It has been established that in the group of reference countries, the expenditures indicator (%) for the pharmaceutical provision of the population from the total spending on health during the period of 1990-2015 fluctuated in a wide range of values. The largest range of values was typical for Belarus (from 3.2 % in 1992 to 29.8 % in 2015), and the smallest for the EU countries (from 16.7 % in 2011 to 18.8 % according to 2003 data). Analyzing the dynamics of changes in this indicator, it was established that there was a tendency towards its decline across the EU and Ukraine, while in Belarus, on the contrary, it was increasing. Thus, in 2015, this indicator increased by 2.5 times, compared with the base data in the 1990 analysis. By the average value in order of magnitude of the indicator that was analyzed, the reference countries were located as follows: Ukraine (10.82 %); RB (14.87 %); EU countries (17.88 %).</p><p><strong>Conclusions.</strong> A significant fluctuation in the values of expenditures (%) allocated for pharmaceutical provision of the population in total health expenditures in the group of countries that were studied was established. In addition, the unstable nature of changes in the indicator that was analyzed in Belarus indicates the need for further research in this direction</p>
Authors and Affiliations
Lyubov Tereshchenko, Irina Zhirova
Keywords
Related Articles
- EP ID EP647853
- DOI 10.15587/2519-4852.2019.177193
- Views 145
- Downloads 0
Research of socio-psychological characteristics of pharmacy specialists
<p>The <strong>purpose</strong> of the article is to study the socio-psychological characteristics of Ukrainian pharmacists.</p><p><strong>Methods</strong><strong>:</strong> methods of psychodiagnostic analysis, expert a...
Оцінка однорідності гелю з екстрактів листя айви й шроту винограду на основі поліметилсилоксану з метою оптимізації та удосконалення технології
<p><strong>Мета. </strong>Оптимізування технології отримання гелю з екстрактами листя айви й шроту винограду на основі поліметилсилоксану для отримання якісного лікарського препарату з оптимальним терміном зберігання.</p...
Scaling of the prospective anti-ulcer API synthesis
<p><strong>Aim</strong>: the scaling of the laboratory procedure for the synthesis of 5-(4-methylphenylaminomethyl-4-(2-methylphenyl)-1,2,4-triazole-4H-3-ylthioacetic acid 4-methoxyanilide (Triazoprazole) for reproductio...
New possibilities of use of oat raw materials for investigation of biologically active components in therapy of experimental diabetes
<p>Aim of the work is to suggest the technology of aqua dynamic extraction of bioactive substances from oat straw. The amount of the extract and the concentration of extracted substances depend on the duration of extract...
Analysis of research on the benefits of clinical and economic effectiveness, safety of innovative drug cetuximab in the treatment of colorectal cancer
<p><strong>The</strong><strong> </strong><strong>aim</strong> of the work is to analyze and systematize literature data on the benefits of clinical and economic efficiency, safety of cetuximab in the treatment of colorec...